2004
DOI: 10.1203/01.pdr.0000139426.16381.c8
|View full text |Cite
|
Sign up to set email alerts
|

Possible Synergic Effect of Angiotensin-I Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-II Type-1 Receptor 1166A/C Gene Polymorphism on Ischemic Heart Disease in Patients with Kawasaki Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(20 citation statements)
references
References 40 publications
0
20
0
Order By: Relevance
“…34,35 The angiotensin-I-converting enzyme gene was reported to be associated with susceptibility to KD but not CAL formation in Taiwan, 36 and it was shown to be associated with the formation of severe coronary artery stenosis and myocardial ischemia in the Japan population. 37 In recent years, it has become clear that the intronic SNP (rs28493229) of ITPKC that is involved in the development of coronary artery abnormalities is an important factor in susceptibility to KD. 14 However, the results obtained from the genetic association study between rs28493229 and KD susceptibility is inconsistent in the Taiwanese population.…”
Section: Discussionmentioning
confidence: 99%
“…34,35 The angiotensin-I-converting enzyme gene was reported to be associated with susceptibility to KD but not CAL formation in Taiwan, 36 and it was shown to be associated with the formation of severe coronary artery stenosis and myocardial ischemia in the Japan population. 37 In recent years, it has become clear that the intronic SNP (rs28493229) of ITPKC that is involved in the development of coronary artery abnormalities is an important factor in susceptibility to KD. 14 However, the results obtained from the genetic association study between rs28493229 and KD susceptibility is inconsistent in the Taiwanese population.…”
Section: Discussionmentioning
confidence: 99%
“…Considering that no significant linkage was detected near the 6p region in our genome-wide linkage analysis, 31 34 and MCP-1 35 ), hematopoietins (interleukin-4 (IL-4) [36][37][38] and IL-6 39 ), IL-1 family (IL-1b, 37 IL-18, 40 and IL-1Ra 37 ), IL-10 family (IL-10 41 ), platelet-derived growth factor family (vascular endothelial growth factor (VEGF) [42][43][44][45] and VEGFR2 42 ), and tumor necrosis factor (TNF) family (TNF-a, 46-50 lipoteichoic acid, 47 and CD40L 51,52 ). Other candidates include plasma proteins (C-reactive protein [53][54][55] and MBL2 53,55,56 ), matrix metalloproteinase (MMP) and their inhibitors (MMP2, 58 MMP3, 57,58 MMP-9, 58 MMP-12, 58 MMP-13, 58 and tissue inhibitors of metalloproteinase-2 59 ), enzymes related to atherosclerosis (methylenetetrahydrofolate reductase (MTHFR), 60 endothelial nitric oxide synthase, 61 and inducible nitric oxide synthase 61 ), components of the renin-angiotensin system (angiotensin-converting enzyme [62][63][64][65] and AGTR1 64 ), and an unclassified group (CD14, 66 FCGR2A, 67,68 SLC11A1, 69 PLA2G7, 70 UGT1A1, 71 MICA, 72 and HMOX1 71 ).…”
Section: Candidate Gene Approachmentioning
confidence: 99%
“…Even with extensive efforts using the genome-wide linkage studies, the responsible genetic determinants remain largely uncategorized [2][3][4]. Genetic epidemiology might provide insights into the pathophysiology of coronary restenosis and easily identifiable markers for predicting an increased restenosis risk [2,4,5]. Despite a lack of good evidence that susceptibility to restenosis is genetically determined, several studies have investigated polymorphisms that might be associated with restenosis [2,3,[5][6][7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Genetic epidemiology might provide insights into the pathophysiology of coronary restenosis and easily identifiable markers for predicting an increased restenosis risk [2,4,5]. Despite a lack of good evidence that susceptibility to restenosis is genetically determined, several studies have investigated polymorphisms that might be associated with restenosis [2,3,[5][6][7][8][9]. Among the most studied genes for its association in pathogenesis of CAD and related outcomes is angiotensin converting enzyme (ACE) gene, located on chromosome 17q23.…”
Section: Introductionmentioning
confidence: 99%